Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
5 Substituted Nucleoside Analogs
Abstract: The present invention relates to novel 5 substituted nucleoside compounds pharmaceutical compositions comprising the compounds and methods of using the compounds to treat cancer more particularly for the treatment of cancer in particular glioblastomas melanoma sarcomas gastric cancer pancreatic cancer cholangiocarcinoma bladder cancer breast cancer non small cell lung cancer leukemias including acute myeloid leukemia and lymphomas.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
21 September 2017
Publication Number
45/2017
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Applicants
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis Indiana 46285
Inventors
1. BONDAY Zahid Quyoom
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis Indiana 46206 6288
2. CORTEZ Guillermo S.
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis Indiana 46206 6288
3. DAHNKE Karl Robert
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis Indiana 46206 6288
4. GROGAN Michael John
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis Indiana 46206 6288
5. HERGUETA Antonio Rodriguez
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis Indiana 46206 6288
6. JAMISON James Andrew
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis Indiana 46206 6288
7. WATSON Brian Morgan
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis Indiana 46206 6288
8. WOODS Timothy Andrew
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis Indiana 46206 6288
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 201727033457-STATEMENT OF UNDERTAKING (FORM 3) [21-09-2017(online)].pdf | 2017-09-21 |
| 2 | 201727033457-SEQUENCE LISTING(PDF) [21-09-2017(online)].pdf | 2017-09-21 |
| 4 | 201727033457-POWER OF AUTHORITY [21-09-2017(online)].pdf | 2017-09-21 |
| 5 | 201727033457-FORM 1 [21-09-2017(online)].pdf | 2017-09-21 |
| 6 | 201727033457-DECLARATION OF INVENTORSHIP (FORM 5) [21-09-2017(online)].pdf | 2017-09-21 |
| 7 | 201727033457-COMPLETE SPECIFICATION [21-09-2017(online)].pdf | 2017-09-21 |
| 8 | 201727033457-FORM 18 [25-09-2017(online)].pdf | 2017-09-25 |
| 9 | 201727033457-Proof of Right (MANDATORY) [06-10-2017(online)].pdf | 2017-10-06 |
| 10 | 201727033457-Information under section 8(2) (MANDATORY) [22-11-2017(online)].pdf | 2017-11-22 |
| 11 | 201727033457-FORM 3 [22-02-2018(online)].pdf | 2018-02-22 |
| 12 | 201727033457.pdf | 2018-08-11 |
| 13 | 201727033457-ORIGINAL UNDER RULE 6 (1A)-ASSIGNMENT-131017.pdf | 2018-08-11 |